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INTRODUCTION
Primary immunodeficiency disease (PID) is a genetically
heterogeneous group of disorders that affect distinct compo-
nents of the innate and adaptive immune system. The car-
dinal manifestations of PID include frequent respiratory and
gastrointestinal tract infections and systemic symptoms, such
as fever, weight loss, and failure to thrive. Recent advances
in molecular biology have identified more than 120 distinct
genes, whose abnormalities account for more than 150 dif-
ferent forms of PID (1). Because of the serious complications
associated with PID and the development of diagnostic tools
in recent year, clinicians have attempted to determine inci-
dence rates of PID via the collection of clinical data at their
home institutions in order to increase diagnosis rates and treat-
ment. However, unreported or undiagnosed subjects remain
unaccounted for. Most studies have been performed in Euro-
pean and North American populations; there have been few
studies that have examined the incidence of PID among dif-
ferent races and ethnic groups. Published registry data have
shown both racial and geographical variation in the preva-
lence and pattern of PID (2, 3). Within the last 10 yr, PID
data from the Middle East and Latin America have been pub-
lished (4-6). In Asia, the prevalence of PID has been largely
unknown, and registries have only been organized in a few
countries (7). In Korea, Lee et al. (8) reported the character-
istic features of various PID disorders in children over 10-yr at
a single center; however, there have only been a few case reports
describing PID in Korean adults . This is the first study to
investigate the clinical features of PID in Korean adults. 
MATERIALS AND METHODS
Patient enrollment, diagnosis, and classification
Fifty-five adult patients who had been diagnosed as hav-
ing PID at Ajou University Hospital in Korea during a peri-
od of 10 yr from January 1998 to January 2009 were enrolled
in the study. Individual diagnoses were based on typical clin-
ical features in conjunction with laboratory abnormalities,
which were categorized according to WHO criteria (1). We
performed laboratory tests on the patients with more than 4
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Immunoglobulin G Subclass Deficiency is the Major Phenotype of 
Primary Immunodeficiency in a Korean Adult Cohort
Primary immunodeficiency disease (PID) is a rare disorder in adults. Most often,
serious forms are detected during infancy or childhood. However, mild forms of PID
may not be diagnosed until later in life, and some types of humoral immunodeficien-
cy may occur in adulthood. The purpose of this study was to identify clinical features
of PID in Korean adults. A retrospective study was performed on 55 adult patients
who were diagnosed as PID between January 1998 and January 2009 at a single
tertiary medical center in Korea. IgG subclass deficiency was the most common
phenotype (67%, 37/55), followed by total IgG deficiency (20%, 11/55), IgM deficien-
cy (7%, 4/55), common variable immunodeficiency (2%, 1/55), and X-linked agam-
maglobulinemia (2%, 1/55). IgG3 and IgG4 were the most affected subclasses.
Upper and lower respiratory tract infections (76%) were the most frequently observed
symptoms, followed by multiple site infection (11%), urinary tract infection, and col-
itis. Bronchial asthma, rhinitis, and several autoimmune diseases were common
associated diseases. IgG and IgG subclass deficiency should be considered in adult
patients presenting with recurrent upper and lower respiratory infections, particu-
larly in those with respiratory allergies or autoimmune diseases.
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1 yr, an unusual organism infection, or an unusual duration
of treatment. Patients with secondary immunodeficiency dis-
eases such as human immunodeficiency virus (HIV) infec-
tion, other viral infections, and chronic systemic steroid or
immunosuppressant use were excluded. Medical records were
reviewed, and all information, including name, sex, age, fam-
ily history, previous medications, clinical presentation, types
of infections and isolated organisms, allergies, and malignant
conversion were recorded. Laboratory analyses were performed
using standard techniques and included complete blood counts,
platelet counts, examination of peripheral blood smears, ery-
throcyte sedimentation rates, and complement hemolytic
activity (CH50) with C3 and C4. Peripheral blood lympho-
cyte subsets were analyzed by flow cytometry using a basic
panel of T-cell subsets (CD3, CD4, and CD8), B-cells (CD19)
and natural killer cells (CD56, CD16). Immunoglobulin G,
A, and M were determined using the immunoturbidimetric
technique. Reference ranges for normal levels were 916-1,796
mg/dL for IgG; 93-365 mg/dL for IgM; and 40-260 mg/dL
for IgA. IgG subclass 1, 2, 3, and 4 concentrations were deter-
mined using the single radial immunodiffusion method. Nor-
mal ranges for IgG subclass are as follows: 315-855 mg/dL
for IgG1; 64-495 mg/dL for IgG2; 23-196 mg/dL for IgG3;
and 11-157 mg/dL for IgG4. IgG subclass deficiency was
diagnosed in this study if the patient’s immunoglobulin lev-
els were 2 standard deviations below the mean of that sub-
class (9, 10). Genetic testing was performed on only one pati-
ent with X-linked agammaglobulinemia. All subjects gave
informed consent, as regulated by the Institutional Review
Boards of Ajou Medical Center, Suwon, Korea (IRB approval
number; AJIRB-CRO-08-215). 
Statistical analysis
Descriptive analyses and Mann-Whitney U tests were per-
formed using the SPSS statistical software package (version
16.0) to evaluate statistical differences. A P value of 0.05 or
less was regarded as statistically significant.
RESULTS
Patient characteristics 
The mean patient age was 42.5±16.12 yr (ranged from
16 to 76), and most patients were diagnosed as PID during
their first visit to the hospital. The patient population was
composed of 34 females and 21 males, with a female-to-male
ratio of 1.61:1. No patients were reported to have a family
history of PID, but related information was limited. Twen-
ty-five patients (25/55, 45.5%) had atopy. Bronchial asthma
(33/55, 60.0%) was the most common associated disease. Five
patients had only allergic rhinitis and others had autoimmune
diseases such as systemic lupus erythematosus (SLE), rheuma-
toid arthritis (RA), and gout. Seven patients (7/55, 12.7%)
had both allergies and an autoimmune disease (Table 1).
Frequency and distribution of PID
In the present study, 55 adult patients were diagnosed as
having PID. All patients were predominantly antibody im-
munodeficient. In contrast to results in children, none of the
patients were identified as having any of the following: com-
bined T- and B-cell immunodeficiency, other well-defined
immunodeficiencies, immune dysregulation, and congenital
defects in phagocyte number and/or function. Within the pre-
dominantly antibody immunodeficiency category, the most
common phenotype was IgG subclass deficiency (n=37, 67.3
%), followed by total IgG deficiency (n=11, 20.0%), IgM
deficiency (n=4, 7.3%), selective IgA deficiency (n=1, 1.8%),
*Current smoker or ex-smoker.
SLE, systemic lupus erythematosus; RA, rheumatoid arthritis.
Sex (male:female)  1:1.61 
Age (yr)  42.5±16.12 (16-76) 
Atopy (positive, %)  25 (45.5%) 
Smoking history*  12 (21.8%) 
Associated disease 
Bronchial asthma  33 (60.0%) 
Allergic rhinitis  5 (9.09%) 
SLE 2 (3.6%) 
RA 2 (3.6%) 
Gout 1  (1.8%) 
Allergic and autoimmune disease  7 (12.7%) 
None 5  (9.1%) 
Total patients (n)  55 













Fig. 1. Distribution of primary immunodeficiency in adult patients
from a single medical center in Korea.826 J.-H. Kim, H.-J. Park, G.-S. Choi, et al.
common variable immunodeficiency (CVID) (n=1, 1.8%) and
X-linked agammaglobulinemia (n=1, 1.8%, Fig. 1). Among
patients with IgG subclass deficiency, IgG3 subclass deficien-
cy was the most common (n=17, 47.2%), followed by IgG4
subclass deficiency (n=9, 25.0%). In total, 16.7% of patients
with IgG subclass deficiency showed multiple IgG subclass
deficiency. Synchronous IgG3 and IgG4 deficiency was most
frequently noted. Only two patients showed different disease
patterns (IgG1 with IgG4 deficiency and IgG1 with IgG2
deficiency). The mean immunoglobulin values in patients with
IgG subclass deficiency were as follows: IgG, 1018.6±380.4
mg/dL; IgA, 226.2±117.7 mg/dL; IgM, 147.5±110.6 mg/
dL; IgG1, 628.6±360.7 mg/dL; IgG2, 392.4±189.9 mg/
dL; IgG3, 29.5±25.0 mg/dL; and IgG4, 28.9±28.8 mg/dL. 
Clinical features
Infectious complications were the major clinical presenta-
tion in patients with PID. Several multiple-site infections were
noted. The most prevalent infections included respiratory tract
infections (including sinusitis), acute pharyngotonsilitis, pneu-
monia, and bronchitis. The least frequently observed infec-
tions were meningitis/encephalitis and genitourinary tract
infection. Six patients (10%) had simultaneous multiple site
infections such as cellulitis with colitis or urinary tract infec-
tion with pneumonia. Respiratory infections were most fre-
quently observed in patients with IgG3 deficiency (Fig. 2A).
Bronchial asthma was related to decreased levels of IgG3, IgG4,
and multiple IgG subclasses. There was a tendency for patients
with autoimmune diseases to have decreased levels of IgG4
(Fig. 2B). Only one patient, who was treated for rheumatoid
arthritis, had no history of infection. No mortality was report-
ed in this study, even though some were lost to follow up.
DISCUSSION
In this study, we found that most adults with PID were
classified as predominantly antibody deficient, with IgG sub-
class deficiency as the most common type. This is consistent
with results from previous papers, which have reported that
IgG subclass deficiency is relatively common (19.4%) in Aus-
tralia (11). IgG subclass deficiency (26%) and hypogamma-
globulinemia (23%) are frequently observed in the USA (12).
In contrast, selective IgA deficiency and CVID have been the
most frequently observed phenotypes in many countries, based
on patients enrolled in a PID registry (4-6, 13, 14). Differ-
ences between the results of this study and the distribution
of PID in other countries could be due to several factors. First,
ethnicity could influence differences in PID distribution. Selec-
tive IgA deficiency was found to occur at a ratio of 1:400 to
1:1,000 in European-related populations, but occurred in only
1:14,840 in Japanese blood donors (2, 3). In a Japanese study,
selective immunodeficiencies other than IgA accounted for
12.3% of pediatric patients with PID, suggesting it is rela-
tively common in Japanese populations, as compared with
western patients (7). Inheritance of the HLA-DR3, HLA-B8,
and HLA-A1 haplotype is associated with both common vari-
able immune deficiency and IgA deficiency in European pop-
ulations. In African American subjects, however, the inci-
dence of HLA-B8 and HLA-A1 antigens was 6 and 7%, res-
pectively, as compared with 16% and 28% for persons of Euro-
pean descent (2, 15). Further, the age of patients in the PID
registry ranged from infancy to old age, whereas the patients
in this study were in adulthood. Finally, the reported num-
ber of PID patients in this study was done in a single center
study. Majority of the subjects were those who visited our hos-
pital due to recurrent respiratory infections or unusual infec-
tions. Therefore, a national PID registry study based on multi-
centers will be needed to evaluate the prevalence, distribu-
tion, risk factors of the PID in the Korean adult population.
An important finding of this study was that IgG3 subclass
deficiency is the most common feature associated with aller-
gic disease, in particular bronchial asthma. These results are
consistent with previous studies that have reported IgG sub-
class deficiency in patients with bronchial asthma or obstruc-
tive lung disease (16-18). Other studies have revealed that
more than 40% of subjects with IgG3 subclass deficiency
have a history of asthma (19) and 41-50% of severe asthmat-
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Fig. 2. Affected IgG subclass of infectious complications (A) and underlying diseases (B) in patients with primary immunodeficiency disease.
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els of IgG subclasses have been associated with an increased
susceptibility to respiratory infections, especially during pri-
mary immune responses to viral protein antigens. In addi-
tion, IgG3 is responsible for the primary immune response
to Moraxella catarrhalis and the M component of Streptococcus
pyogenes, which are the pathogens responsible for exacerbation
of upper and lower respiratory infections (20, 21). According
to data from the PID registry in Iran, 10 cases of selective IgG
subclass deficiency presented with recurrent respiratory infec-
tions (4). Recent studies show that 45% of Korean patients
with bronchiectasis, who suffered from recurrent respiratory
infections, had IgG3 subclass deficiency (21). We hypothe-
size that IgG3 subclass deficiency is associated with defense
mechanisms against viral and atypical pathogen infection,
which occur in recurrent upper and lower respiratory infec-
tions and the exacerbation of asthma symptoms. 
Another finding in this study was that patients diagnosed
with SLE or RA had a tendency to present with IgG4 sub-
class deficiency. Among five patients diagnosed with autoim-
mune diseases such as SLE or RA, three patients had selective
IgG4 deficiency and two patients had combined IgG subclass
deficiency (IgG3 and IgG4, IgG1 and IgG4). Epidemiolog-
ical data have shown that some PID is systematically associ-
ated with autoimmune disease. Autoimmune manifestations
may occur in PID with variable frequency and include CVID,
hyper-IgM syndrome, Good syndrome, and Wiskott-Aldrich
syndrome. Rakay, et al. detected the IgG subclass imbalance
in 16 patients with connective tissue disease (22). There was
also a case report about a 7 yr old boy with IgG2 and IgG4
subclass deficiency who presented with cardiac tamponade
due to SLE (23). PID may result in defects in control mech-
anisms for self-reactive B and T cells, thus favoring the occur-
rence of autoimmune manifestations. With the exception of
one patient, all subjects in this study who were diagnosed as
having an autoimmune disease with IgG4 selective deficien-
cy had a history of infections. Although IgG4 represents only
a minor portion of total IgG, it may nevertheless be of clini-
cal importance. IgG4 deficient individuals have been report-
ed to suffer from recurrent infections. Heiner suggested that
selective IgG4 deficiency might play a role in adult patients
with bronchiectasis (24). In pediatric patients, the association
between selective IgG4 deficiency and recurrent respiratory
infections has been reported. Isolated or combined IgG4 defi-
ciency was most commonly affected, as compared with other
isotypes of IgG subclasses in childhood patients (25). In anoth-
er study, the role of selective IgG4 deficiency in infection-sus-
ceptibility was not determined, because it occurred in nor-
mal individuals. Approximately 10 to 15% of the general
population has IgG4 concentrations below the limit of detec-
tion (24). Based on results of previous studies, selective IgG4
deficiency is related to infection and autoimmune diseases.
To elucidate the exact role of IgG4, additional clinical and
experimental data are needed. 
With the development of available genetic testing, more
than 120 distinct genes have been identified that may be in-
volved in various forms of PID. Nevertheless, the pathogen-
esis of IgG subclass deficiency remains largely unknown. In
a few cases, homozygous deletions of the corresponding C
region genes were documented. But, most cases of IgG sub-
class deficiency are due to the aberrant regulation of immu-
noglobulin heavy constant chain gene (IGHG) expression,
which is influenced in both a positive and negative manner
by various cytokines and B-cell activators (26). Recently, the
tumor necrosis factor receptor family member TACI (trans-
membrane activator and calcium-modulator and cyclophilin
ligand interactor) has been found to mediate isotype switch-
ing in B cells, which is associated with CVID, selective IgA
deficiency, and IgG subclass deficiency (27, 28). Based on the
observed infectious complications and B cell isotype switch-
ing in patients with IgG subclass deficiency, it is possible that
some pathogens (viral or bacterial) could influence isotype
switching in B cells, which may cause IgG subclass deficien-
cy in particular patients diagnosed as having bronchial asthma.
The treatment of choice for antibody deficiency is intra-
venous immunoglobulin (IVIG) replacement therapy (19,
29, 30). Adequate replacement of IVIG has been shown to
reduce the incidence of pneumonia and prevent the progres-
sion of lung disease in patients with PID. Similar effects of
IVIG were noted in the patients with IgG subclass deficien-
cy. Subjects in this study were administrated IVIG monthly;
IVIG significantly improved quality of life, decreased the num-
ber of infections and the need for antibiotics, and improved
IgG subclass levels (30). When IVIG was used as a prophy-
laxis, significant protection against infection was noted (19). 
In conclusion, this is the first study of adult PID from a
single tertiary medical center in Korea. IgG subclass defi-
ciency was the most common disease in adult patients and
IgG3 and IgG4 were commonly affected. The main clinical
presentations included infectious complications, especially
respiratory infections. Therefore, IgG subclass deficiency
should be considered in adult patients with recurrent upper
and lower respiratory infections, particularly in those with
asthma or autoimmune diseases. 
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